PEER-REVIEW | BREAST IMPLANT COMPLICATIONS |
and is replaced by well-organised host tissue 11
. The
mesh became fully absorbed at 36 months post- implantation 12
. This gives it the ability to aid in tissue
support for a long period of time. These qualities make it an ideal reinforcement in revisionary surgery after breast implant complications. TIGR® Matrix was shown to be efficacious in the patient
featured in this article who presented with a breast implant complication. Excellent functional and aesthetic improvements were made with the revision. To date, the authors have used this surgical mesh in over 40 breast revision cases with very good results and patient
TIGR® Matrix is the first synthetic
long-term resorbable surgical mesh. It is a copolymer of glycolide, lactide, and trimethylene carbonate.
satisfaction. The authors continue to find new ways to use it in breast surgery, such as primary reconstruction, reconstruction revision, augmentation/mastopexy revision, and breast implant revision and are consistently happy with the results.
Conclusions Based on the case presented in this article and other cases like it, the authors believe the long-term synthetic
References
1. American Society of Plastic Surgeons website. 2011 Plastic Surgery Procedural Statistics. www.
plasticsurgery.org/News-and- Resources/
2011-Statistics-.html (accessed 18 March 2013)
2. Hvilsom GB, Hölmich LR, Henriksen TF, Lipworth L, McLaughlin JK, Friis S. Local complications after cosmetic breast augmentation: results from the danish registry for plastic surgery of the breast. Plast Surg Nurs 2010; 30 (3): 172–9
3. Lesavoy MA, Trussler AP, Dickinson BP. Difficulties with subpectoral augmentation
32 ❚
mammaplasty and its correction: the rold of subglandular site change in revision aesthetic breast surgery. Plast Reconstr Surg 2010; 125 (1): 363–71
4. Hjort H, Mathisen T, Alves A, Clermont G, Boutrand JP. Three-year results from a preclinical implantation study of a long-term resorbable surgical mesh with time-dependent mechanical characteristics. Hernia 2012; 16: 191–7
5. Chen OW. 12 month tram data collated using TIGR® matrix surgical mesh in a randomized controlled study. Paper presented at: 2012
Malaysian Association of Plastic, Aesthetic, and Craniomaxillofacial Surgeons; March 31, 2012; Penang, Malaysia
6. Prospective clinical trial on 40 patients with primary inguinal hernia repairs. Novus Scientific. Data on File
7. Stevens WG, Harrington J, Alizadeh K et al. Five-year follow-up data from the U.S. clinical trial for sientra’s U.S. food and drug administration -approved silimed brand round and shaped implants with high-strength silicone gel. Plast Reconstr Surg 2012; 130 (5): 973–81
8. Hartzell TL, Taghinia AH, Chang J, Lin SJ, Slavin SA. The use of human acellular dermal matrix for the correction of secondary deformities after breast augmentation: results and costs. Plast Reconstr Surg 2010; 126 (5): 1711–20
9. Spear SL, Seruya M, Clemens MW, Teitelbaum S, Nahabedian MY. Acellular dermal matrix for the treatment and prevention of implant-associated breast deformities. Plast Reconstr Surg 2011; 127: 1047–58
10. Slavin SA, Lin SJ. The use of acellular dermal matrices in
revisional breast reconstruction. Plast Reconstr Surg 2012; 130 (5S2): 70S–85S
11. Becker H. Advances in breast reconstruction and revision withTIGR® Resorbable Matrix. ISAPS GENEVA 21st congress. Geneva, September 2012.
12. Hjort H, Mathisen T, Alves A et al. Three-year results from a preclinical implantation study of a long-term resorbable surgical mesh with time-dependent mechanical characteristics. Hernia 2012; 16: 191–7
Key points
■ TIGR® Matrix is the first synthetic long-term resorbable surgical mesh
■ Pre-clinical trials of this mesh show that it is vascularised very rapidly and is replaced by well-organised host tissue
■ Synthetic absorbable mesh offers a viable alternative to acellular dermal matrices in breast surgery procedures
Figure 4 (A) 3 weeks postoperative result following replacement of implants in the sub-fascial position with mesh support and (B) 3 weeks postoperative, lateral view
resorbable mesh, TIGR® Matrix, is a very useful tool in the correction of certain complications resulting from implant-based breast surgery. However, for patients who have undergone radiation treatment, the result can be slower healing and incorporation of the mesh implant. Further studies on the uses of the TIGR Matrix are ongoing.
Declaration of interest Dr Becker is a consultant for
Novus Scientific All figures © Dr Lind and Dr Becker
May/June 2013 |
prime-journal.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76